News GSK passes to Magic Johnson for RSV awareness drive GSK said basketball legend will help spark “important conversations” about RSV in older adults.
News GSK hits back in 5-in-1 meningitis jab contest with Pfizer Phase 3 trial sets up filing for GSK's MenABCWY vaccine, several months later than its rival.
News Mersana stung by FDA hold on STING drug Death in ph1 trial casts a pall over GSK-backed project, licensed for $100m upfront last year.
News GSK wins the vote contest in FDA’s RSV vaccine panels Advisory committee votes unanimously that RSVPreF3 shot is effective, and 10-2 on safety.
News Pfizer’s RSV shot clears FDA adcomm; now it’s GSK’s turn There was debate about cases of Guillain Barré and the population of the phase 3 RENOIR trial.
News GSK scores regular FDA approval for PD-1 inhibitor Jemperli The checkpoint inhibitor secured confirmatory approval after an accelerated nod back in 2021.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
